Cycloanthranilylproline-derived constituents from a myxomycete Fuligo candida

Chemical and Pharmaceutical Bulletin

Volumn 52, Issue 3, 2004, Pages 368-370

  Nakatani, Satomi ^a   Yamamoto, Yukinori ^b   Hayashi, Masahiko ^c   Komiyama, Kanki ^c   Ishibashi, Masami ^a  

^a CHIBA UNIVERSITY   (Japan)

^b Kitasato Institute ^*  (Japan)

^c KITASATO INSTITUTE   (Japan)

Author keywords

Cycloanthranilylproline; Fuligo candida; Myxomycete

Indexed keywords

CYCLOANTHRANILYLPROLINE; PROLINE DERIVATIVE; UNCLASSIFIED DRUG; DRUG DERIVATIVE; PROLINE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CARBOXYLATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; DRUG ISOLATION; DRUG STRUCTURE; FRUITING BODY; FULIGO CANDIDA; LEUKEMIA CELL; MOUSE; MYXOMYCETES; NONHUMAN; SPECTROSCOPY; STRUCTURE ANALYSIS; CHEMICAL STRUCTURE; CHEMISTRY; ISATIS; ISOLATION AND PURIFICATION; JAPAN; NUCLEAR MAGNETIC RESONANCE;

ISATIS; JAPAN; MOLECULAR STRUCTURE; MYXOMYCETES; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PROLINE;

EID: 4544322708     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.52.368     Document Type: Article

References (7)

1. Ishibashi M., J. Synth. Org. Chem. Jpn., 61, 152-163 (2003).
2. Naoe A., Ishibashi M., Yamamoto Y., Tetrahedron, 59, 3433-3435 (2003).
3. Iwata D., Ishibashi M., Yamamoto Y., J. Nat. Prod., 66, 1611-1612 (2003).
4. Nakatani S., Naoe A., Yamamoto Y., Yamauchi T., Yamaguchi N., Ishibshi M., Bioorg. Med. Chem. Lett., 13, 2879-2881 (2003).
5. Wu X., Liu Y., Sheng W., Sun J., Qin G., Planta Medica, 63, 55-57 (1997).
6. Brown T. B., Stevens M. F. G., J. Chem. Soc., Perkin Trans. 1, 1975, 2357-2360 (1975).
7. Rho M.-C., Hayashi M., Fukami A., Obata R., Sunazuka T., Tomoda H., Komiyama K., Ōmura S., J. Antibiot., 53, 1201-1206 (2000).